# Challenge

New emerging therapies offer hope for Alzheimer's Disease by slowing disease progression. To maximise efficacy, these drugs should ideally be administered early in the diseaseâ€™s progression, well before symptoms have manifested themselves. Reliable biomarkers enable the full effectiveness of these therapies to be realised.
